Reverse Transcriptase Inhibitors in AGS
A Study of AGS-1C4D4 in Pancreatic Cancer Subjects Previously Treated in Protocol 2008002
A Study of AGS-1C4D4 Given in Combination With Gemcitabine in Subjects With Metastatic Pancreatic Cancer
AGS-1C4D4 in Patients With Advanced Hormone Refractory Prostate Cancer
† Study has passed its completion date and status has not been verified in more than two years.